
Henry Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: compounded semaglutide by injection or tablet, with visits and supplies in one monthly bill
Henry Meds scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Henry Meds’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Established compounded GLP-1 telehealth provider offering both injectable and oral formats.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Henry Meds?
Henry Meds is a cash-pay telehealth service that connects adults with licensed providers who can prescribe compounded GLP-1 medication, mainly semaglutide as a weekly injection or a dissolving tablet, with an oral tirzepatide option too. One plan price covers your provider visits, medication, supplies, shipping, and ongoing care, so it suits people who want a simple bill and don't plan to use insurance.
Vetted alternatives to Henry Meds
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Henry Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- Pricing model
- Scales with dose: higher doses cost more
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Henry Meds
Each dimension is scored algorithmically from Henry Meds’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $179/mo, Henry Meds runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.2/10Henry Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.1/10Online intake and platform experience (consult included in the price); 4 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.1/10Henry Meds's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.9/10Henry Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Henry Meds review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $179–$349/mo across 4 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Henry Meds
We walked Henry Meds’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Share your medical details online (stated to take less than 5 minutes).
- 2Speak with a healthcare provider to determine if treatment is right for you.
- 3If prescribed, medication and supplies are mailed straight to your door.
- One bundled monthly payment covers the provider visit, medication and supplies, and ongoing care. Henry's GLP-1 page says plans start at $179 a month, and its program terms page lists every plan price before you start the questionnaire.
- Provider consult can be a video call or, depending on your state, an independent provider review without a video call.
- Most people receive medication within 8-10 business days after speaking to their provider.
- Monthly plans can be canceled at any time; multi-month plans may require full payment.
- Offers phentermine and other treatments alongside GLP-1; a refunds policy is linked but terms are not detailed on-page.
Henry Meds customer support
- Phone
- (909) 787-2342
- ask@henrymeds.com
GLP-1 medications Henry Meds offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'Weekly or Biweekly Injections (Semaglutide) $297 per month' on Henry's program terms page; medication ships every 70 or 90 days. Longer plans: 6 months for $1,782 ($1,482 if paid in full), 12 months for $3,564 ($2,364 if paid in full).
'Sublingual Semaglutide (Tablets or Drops)' in Henry's Premium Non-Injectable program; up to 60 mg every 60 days. Longer plans: 6 months for $1,074 ($1,014 if paid in full), 12 months for $2,148 ($1,788 if paid in full).
'Sublingual Semaglutide Tablets $249 per month'; up to 180 mg every 60 days. Longer plans: 6 months for $1,074 ($1,014 if paid in full), 12 months for $2,148 ($1,788 if paid in full). Also sold as a 3-month oral supply for $747 ($537 if paid in full).
Henry's program terms: 'Tirzepatide Oral (3-Month Supply) $1,047 ($891 if paid in full)'. $349/mo is $1,047 over three months; paying the $891 in full up front works out to $297/mo. Sold only as a 3-month supply.
Ready to get started?
Plans and promotions change often, so check Henry Meds's current pricing and active discounts before you decide.
What we like
- Plans from $179/mo include provider visits, medication, supplies, shipping and ongoing care
- Semaglutide by weekly injection, under-the-tongue tablets or drops
- Also offers compounded liraglutide and oral tirzepatide
- Publishes its full program price list, including longer-plan discounts
- No long-term contract on monthly plans
Watch-outs
- Tirzepatide comes only as a 3-month oral tablet supply; there's no monthly tirzepatide injection plan
- Canceling a multi-month plan may require paying the rest of the balance
- Prescription medication is final sale once shipped, and the $30 consultation fee is non-refundable once a prescription is issued
- The states it serves aren't listed publicly
Henry Meds: a mainstream pick for people who want options
Henry Meds is one of the more established names in compounded GLP-1 telehealth, and its main appeal is breadth. Most online weight-loss programs hand you a single drug in a single format and call it a day. Henry Meds gives you compounded semaglutide as a weekly injection or as under-the-tongue tablets or drops, plus tirzepatide as an orally dissolving tablet. If you are needle-averse, or you simply want the freedom to switch medications or formats without changing providers, that flexibility is the main reason to look here.
This is a solid, middle-of-the-road choice rather than a budget standout. Its entry price sits near the category median, injections cost more, and the trade-off you are paying for is selection and an all-inclusive plan, not the lowest possible number.
How the pricing works
Henry Meds sets a fixed monthly price for each program, and the price varies with the medication, format, and supply you are on, so there is no single sticker number that applies to everyone. Plans start at $179 a month for sublingual semaglutide tablets or drops in the lower supply, and injectable semaglutide is $297 a month. Tirzepatide is sold only as a 3-month oral supply for $1,047 ($891 if paid in full). For context, the category median across the providers we track is about $179, so Henry's entry plan sits near the median and its injection plan well above it.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
What you do get for that price is bundled. Henry is explicit that your provider visits, the medication itself, supplies, shipping, and ongoing care are all rolled into the plan price, with what it describes as no hidden or surprise charges. Its refund policy adds one detail: $30 of that bundled billing is a consultation fee for each evaluation that results in a prescription, and it is non-refundable once the prescription is issued. That matters, because some cheaper-looking competitors bolt on a membership or visit fee that erases the difference. Henry does not run a one-time teaser rate to lure you in; the entry price is just its lowest-supply plan.
- Injectable semaglutide: the standard weekly shot most patients picture
- Sublingual semaglutide: tablets or drops for people who would rather skip needles entirely
- Tirzepatide: the dual-action medication, sold only as a 3-month supply of orally dissolving tablets
- Everything bundled: visits, medication, supplies, shipping, and follow-up care in one plan price
The medications and how you get them
Everything Henry dispenses for weight management is compounded, not brand-name. That is the standard model for affordable GLP-1 access right now, and it is the reason the monthly cost is a fraction of the over-a-thousand-dollars-a-month list price you would face for branded pens at the pharmacy counter. It also means you are relying on a compounding pharmacy rather than the original manufacturer, which is a distinction to understand before you sign up.
The format choice is where Henry earns its keep. Offering compounded semaglutide as both an injection and a sublingual option, plus oral tirzepatide on top, covers most of the decisions a new patient might agonize over. You can start with a tablet to see how you tolerate the medication and move to the injection later, or switch from semaglutide to tirzepatide if your results stall, all without leaving the platform. Just note that the tirzepatide tablets come only in a prepaid 3-month supply.
What sets Henry apart, and where it stays quiet
Henry's differentiator is simple: it is a known, high-volume operator with the widest everyday menu among compounded providers. For a lot of people, that name recognition and one-stop selection is exactly what they want from a first GLP-1 program.
The flip side is that Henry is less transparent than we would like on the operational details. It does not publish the list of states it serves. The site only tells you to check whether you live or have an address in a supported state. One notable wrinkle: California orders can take longer to fulfill because of additional compound testing. It also names no specific accredited compounding pharmacy partner in its public materials (smaller sellers such as NativeMed do name theirs), and overall there is limited public information about the finer points of the program. None of that is a red flag on its own, but it does mean you will confirm some specifics only after you start the intake.
Who should choose it, and who should skip it
Choose Henry Meds if you value flexibility and a trusted name over rock-bottom pricing: you want both major GLP-1 drugs available, you might want the oral option, and you would rather have one bundled, no-surprise-fee plan than hunt for the cheapest line item. It is a particularly comfortable on-ramp for first-timers who want mainstream, well-trodden access.
Skip it if price is your single deciding factor. Several compounded providers undercut Henry's ongoing rate. Also think twice if you live in California and need medication fast. The same goes if you want every detail (exact state coverage, the named pharmacy) spelled out before you hand over any information. Henry holds some of that back until intake. If you want a single number to plan around, Good Life Meds charges one flat monthly price at every dose, with no membership fee. If lifestyle coaching matters more to you than menu breadth, Broose Wellness pairs its compounded GLP-1s with coaching and posts its prices openly.
Trust, safety, and medical oversight
There are no FDA warning letters on file for Henry Meds, which is a positive baseline. Treatment is delivered through licensed providers. At the same time, the disclosure gaps noted above matter. Henry does not publicly name its compounding pharmacy or its accreditation, so that part of the supply chain is something you take on trust in a way you don't with providers who publish it. You can see how we weigh these factors in our scoring methodology.
The bottom line
Henry Meds is a dependable, flexible, mainstream choice that trades the lowest price for the widest selection and a clean, all-inclusive plan. The medication menu (semaglutide by injection or tablet, plus oral tirzepatide) is its strongest card, and the no-extra-fees structure is reassuring. Go in knowing that injections and tirzepatide cost more than the entry plan, that California fulfillment runs slow, and that a few program specifics only surface once you start the intake. For many people that is a fair deal; bargain hunters and detail-demanders can do better elsewhere.
The Bottom Line
Henry Meds scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Henry Meds?
From $179/mo. See current pricing and start your free consultation.
Henry Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Henry Meds vs…
Henry Meds scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.

Henry Meds vs Found
Found scores 8.3/10
Henry Meds vs Zealthy
Zealthy scores 5.5/10
Henry Meds vs Amazon One Medical
Amazon One Medical scores 8.5/10

Henry Meds vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Henry Meds review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Henry Meds's current pricing
Plans from $179/mo. Start your free consultation to check eligibility and today's price.